Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: GLP guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2008
Report date:
2008

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: Kouseisho-21 Yakuhatsu-424
GLP compliance:
yes
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
L-serine
EC Number:
200-274-3
EC Name:
L-serine
Cas Number:
56-45-1
Molecular formula:
C3H7NO3
IUPAC Name:
L-serine

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
- Sprague-Dawley strain SPF rats [Crl:CD(SD)]
- Test period: 2007.10.17 - 2008.01.31

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Doses:
2000 mg/kg b.w.
No. of animals per sex per dose:
5
Control animals:
not specified
Details on study design:
L-Serine was administrated once each to groups of 5 males and 5 female Sprague-Dawley strain SPF rats [Crl:CD(SD)] at one dose level of
2,000 mg/kg.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No death occurred in males and females in any test article group. Therefore, the lethal dose level was estimated to be higher than 2,000 mg/kg for
L-serine.
Clinical signs:
other: There were no abnormalities in clinical signs in any male or female animal during the observation period.
Gross pathology:
There were no abnormalities in the external appearance, or in organs/tissues in the cranial, thoracic or abdominal regions in any male or female
animals.

Applicant's summary and conclusion

Interpretation of results:
study cannot be used for classification
Remarks:
Migrated information
Conclusions:
Based on the results of the study report, it was estimated that the toxicity of L-serine was extremely low.